Literature DB >> 12471589

Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy.

Elizabeth R Jenny-Avital1, Maria Abadi.   

Abstract

Five of 10 patients who commenced successful highly active antiretroviral therapy (HAART) for infection with human immunodeficiency virus type 1 (HIV-1) concurrent with or soon after a diagnosis of cryptococcal infection experienced clinical events characterized by sterile inflammation. Two patients developed aseptic meningitis with elevated intracranial pressure, 1 developed intrathoracic lyphadenopathy with hypercalcemia, 1 developed cavitary pneumonia at the site of a cryptococcal nodule, and 1 developed a supraclavicular abscess. These events occurred 2-11 months after initiation of HAART. For 3 patients, biopsy demonstrated findings atypical for acquired immunodeficiency syndrome-associated cryptococcosis. Results of fungal cultures were negative for all 5 patients, and cryptococcal antigen levels had declined markedly in 4 patients. The timing and clinical features of and biopsy findings for these cases of cryptococcosis suggest the existence of a paradoxical reaction to Cryptococcus infection that occurs in the context of HIV immune restoration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471589     DOI: 10.1086/344467

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

Review 1.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

2.  Ward Round: a jaundiced 43 year old man with cavitary lessions on chest radiograph.

Authors:  T Hartung; J van Oosterhout
Journal:  Malawi Med J       Date:  2007-09       Impact factor: 0.875

3.  HIV infection mimicking autoimmune disorder.

Authors:  Jhuma Sankar; Dinesh Raj; Jeeva Sankar; Pradeep K Sharma; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

4.  Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.

Authors:  Chih-Chin Kao; Vin-Cent Wu; Hsin-Yun Sun; Che-Hsiung Wu
Journal:  Int Urol Nephrol       Date:  2012-05-25       Impact factor: 2.370

5.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

Review 6.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

Review 7.  The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.

Authors:  David B Meya; Yukari C Manabe; David R Boulware; Edward N Janoff
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

Review 8.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

9.  Cavitating pneumonia after treatment with infliximab and prednisone.

Authors:  S M Arend; E J Kuijper; C F Allaart; W Hissink Muller; J T Van Dissel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-23       Impact factor: 3.267

10.  Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

Authors:  Anali Conesa-Botella; Chantal Mathieu; Robert Colebunders; Rodrigo Moreno-Reyes; Evelyne van Etten; Lut Lynen; Luc Kestens
Journal:  AIDS Res Ther       Date:  2009-04-21       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.